PRECIGEN Investors


Webcast: Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis

Jun 03, 2024 at 6:00 PM CDT

Precigen webcast following the late-breaking oral presentation of results from the pivotal study of PRGN-2012 for the treatment of recurrent respiratory papillomatosis (RRP) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

Supporting Materials